Open Access

ASCVD & residual risk: recent clinical insights with icosapent ethyl.

Topic: Lipid-Lowering Agents
Organised by PACE-CME - Supported by an unrestricted educational grant from Amarin Pharma

Congress Presentation

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
39 presentations
7 followers

4 more presentations in this session

Introduction.

Speaker: Professor L. Badimon (Barcelona, ES)

Thumbnail

A continuum of multifactorial benefits of icosapent ethyl.

Speaker: Professor M. Back (Stockholm, SE)

Thumbnail

Integrating icosapent ethyl in clinical practice: which patients will benefit?

Speaker: Professor S. Verma (Toronto, CA)

Thumbnail

Discussion.

Speaker: Professor L. Badimon (Barcelona, ES)

Thumbnail

Access the full session

New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice

Speakers: Professor D. Bhatt, Professor L. Badimon, Professor M. Back, Professor S. Verma, Professor L. Badimon
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb